{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-097730","form_type":"8-K","ticker":"TLSI","cik":"0001826667","company_name":"TriSalus Life Sciences, Inc.","filed_at":"2023-09-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.518649+00:00","generated_at":"2026-06-11T00:42:15.434967+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"low","headline":"TriSalus Life Sciences furnishes September 2023 investor slide deck; no material new information disclosed","bullets":["Slide deck posted on company website for investor use; no earnings, guidance, or corporate updates provided.","Presentation reiterates mission to treat liver and pancreatic tumors through immunotherapy and drug delivery technology.","No changes in financial position, operations, or management disclosed; filing is routine Regulation FD disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-097730","json":"https://secwatch.observer/filing/0001104659-23-097730.json","markdown":"https://secwatch.observer/filing/0001104659-23-097730.md","text":"https://secwatch.observer/filing/0001104659-23-097730.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826667/000110465923097730/0001104659-23-097730-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826667/000110465923097730/tm2325342d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T00:42:15.434967+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}